Birdwatch Note
2023-11-30 20:05:21 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
The drug in question is called Tafamidis; it was developed in 2011. Nine years before COVID-19 had spread across the world and 10 years before COVID vaccines were present, the medication was FDA-approved in 2019 and approved by the European Union in 2011. https://www.reuters.com/article/us-pfizer-approval-idUSKCN1SC0VX/ https://en.wikipedia.org/wiki/Tafamidis#:~:text=Tafamidis%20was%20approved%20in%20the,and%20in%20Japan%20in%202013
Written by F6700CE6C398D88F68989BD0B4936602C790E4F7DAA7C6B0AB49AE53BD11CCC4
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1730251533214765155
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1730317110704742574
- noteId - 1730317110704742574
- participantId -
- noteAuthorParticipantId - F6700CE6C398D88F68989BD0B4936602C790E4F7DAA7C6B0AB49AE53BD11CCC4 Participant Details
- createdAtMillis - 1701374721587
- tweetId - 1730251533214765155
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The drug in question is called Tafamidis; it was developed in 2011. Nine years before COVID-19 had spread across the world and 10 years before COVID vaccines were present, the medication was FDA-approved in 2019 and approved by the European Union in 2011. https://www.reuters.com/article/us-pfizer-approval-idUSKCN1SC0VX/ https://en.wikipedia.org/wiki/Tafamidis#:~:text=Tafamidis%20was%20approved%20in%20the,and%20in%20Japan%20in%202013
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-11-30 20:05:21 UTC (1701374721587) |
1969-12-31 23:59:59 UTC (-1) |
2023-12-01 03:12:04 UTC (1701400324779) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-11-30 18:19:52 -0600 | Rating Details | |
| 2023-11-30 18:18:34 -0600 | Rating Details | |
| 2023-11-30 18:12:19 -0600 | Rating Details | |
| 2023-11-30 17:06:53 -0600 | Rating Details | |
| 2023-11-30 16:35:45 -0600 | Rating Details | |
| 2023-11-30 16:30:13 -0600 | Rating Details | |
| 2023-11-30 16:23:29 -0600 | Rating Details | |
| 2023-11-30 16:21:00 -0600 | Rating Details | |
| 2023-11-30 15:25:43 -0600 | Rating Details | |
| 2023-11-30 15:22:53 -0600 | Rating Details | |
| 2023-11-30 15:16:12 -0600 | Rating Details | |
| 2023-11-30 15:15:57 -0600 | Rating Details | |
| 2023-11-30 15:09:37 -0600 | Rating Details | |
| 2023-11-30 15:03:42 -0600 | Rating Details | |
| 2023-11-30 15:00:23 -0600 | Rating Details | |
| 2023-11-30 14:49:18 -0600 | Rating Details | |
| 2023-11-30 14:49:09 -0600 | Rating Details | |
| 2023-11-30 14:46:32 -0600 | Rating Details | |
| 2023-11-30 14:20:14 -0600 | Rating Details | |
| 2023-11-30 14:19:23 -0600 | Rating Details | |
| 2023-12-01 15:24:11 -0600 | Rating Details | |
| 2023-12-01 14:13:21 -0600 | Rating Details | |
| 2023-12-01 09:01:50 -0600 | Rating Details | |
| 2023-12-01 08:39:09 -0600 | Rating Details | |
| 2023-12-01 07:30:36 -0600 | Rating Details | |
| 2023-12-01 06:49:01 -0600 | Rating Details | |
| 2023-12-01 05:43:07 -0600 | Rating Details | |
| 2023-12-01 04:41:51 -0600 | Rating Details | |
| 2023-12-01 03:52:38 -0600 | Rating Details | |
| 2023-12-01 02:42:35 -0600 | Rating Details | |
| 2023-12-01 02:32:24 -0600 | Rating Details | |
| 2023-12-01 01:27:49 -0600 | Rating Details | |
| 2023-12-01 00:30:31 -0600 | Rating Details | |
| 2023-12-01 00:10:24 -0600 | Rating Details | |
| 2023-12-01 00:07:02 -0600 | Rating Details | |
| 2023-12-01 00:02:33 -0600 | Rating Details | |
| 2023-11-30 23:57:20 -0600 | Rating Details | |
| 2023-11-30 23:21:28 -0600 | Rating Details | |
| 2023-11-30 23:16:29 -0600 | Rating Details | |
| 2023-11-30 23:15:00 -0600 | Rating Details | |
| 2023-11-30 23:04:41 -0600 | Rating Details | |
| 2023-11-30 23:00:41 -0600 | Rating Details | |
| 2023-11-30 21:44:39 -0600 | Rating Details | |
| 2023-11-30 21:00:49 -0600 | Rating Details | |
| 2023-11-30 20:43:17 -0600 | Rating Details | |
| 2023-11-30 20:30:32 -0600 | Rating Details | |
| 2023-11-30 19:52:53 -0600 | Rating Details | |
| 2023-11-30 19:47:45 -0600 | Rating Details | |
| 2023-11-30 19:44:35 -0600 | Rating Details | |
| 2023-11-30 19:30:56 -0600 | Rating Details | |
| 2023-11-30 18:58:35 -0600 | Rating Details | |
| 2023-11-30 18:23:52 -0600 | Rating Details | |
| 2023-11-30 17:59:25 -0600 | Rating Details | |
| 2023-11-30 17:41:08 -0600 | Rating Details | |
| 2023-11-30 17:39:43 -0600 | Rating Details | |
| 2023-11-30 17:27:57 -0600 | Rating Details | |
| 2023-11-30 16:59:40 -0600 | Rating Details | |
| 2023-11-30 16:47:59 -0600 | Rating Details | |
| 2023-11-30 16:40:42 -0600 | Rating Details | |
| 2023-11-30 16:40:09 -0600 | Rating Details | |
| 2023-11-30 16:35:01 -0600 | Rating Details | |
| 2023-11-30 16:12:42 -0600 | Rating Details | |
| 2023-11-30 16:01:59 -0600 | Rating Details | |
| 2023-11-30 15:53:08 -0600 | Rating Details | |
| 2023-11-30 15:44:58 -0600 | Rating Details | |
| 2023-11-30 15:33:28 -0600 | Rating Details | |
| 2023-11-30 15:12:09 -0600 | Rating Details | |
| 2023-11-30 14:32:19 -0600 | Rating Details | |
| 2023-11-30 14:29:58 -0600 | Rating Details | |
| 2023-11-30 14:28:48 -0600 | Rating Details | |
| 2023-11-30 14:27:17 -0600 | Rating Details | |
| 2023-11-30 14:21:23 -0600 | Rating Details | |
| 2023-11-30 14:16:10 -0600 | Rating Details | |
| 2023-12-02 07:11:55 -0600 | Rating Details | |
| 2023-12-01 18:05:07 -0600 | Rating Details | |
| 2023-12-01 15:20:12 -0600 | Rating Details | |
| 2023-12-01 12:00:51 -0600 | Rating Details | |
| 2023-12-01 11:23:29 -0600 | Rating Details | |
| 2023-12-01 08:41:56 -0600 | Rating Details | |
| 2023-12-01 08:27:59 -0600 | Rating Details | |
| 2023-12-01 05:32:17 -0600 | Rating Details | |
| 2023-12-01 05:07:00 -0600 | Rating Details | |
| 2023-12-01 04:58:23 -0600 | Rating Details | |
| 2023-12-01 03:59:38 -0600 | Rating Details | |
| 2023-12-01 03:57:04 -0600 | Rating Details | |
| 2023-12-01 03:02:31 -0600 | Rating Details | |
| 2023-12-01 02:31:37 -0600 | Rating Details | |
| 2023-12-01 01:26:22 -0600 | Rating Details | |
| 2023-12-01 00:01:46 -0600 | Rating Details | |
| 2023-11-30 23:28:46 -0600 | Rating Details | |
| 2023-11-30 23:06:39 -0600 | Rating Details | |
| 2023-11-30 22:27:36 -0600 | Rating Details | |
| 2023-11-30 22:17:47 -0600 | Rating Details | |
| 2023-11-30 20:55:53 -0600 | Rating Details | |
| 2023-11-30 20:19:38 -0600 | Rating Details | |
| 2023-11-30 20:16:22 -0600 | Rating Details | |
| 2023-11-30 19:29:51 -0600 | Rating Details | |
| 2023-12-02 06:26:42 -0600 | Rating Details | |
| 2023-12-05 10:36:04 -0600 | Rating Details | |
| 2023-12-05 07:47:28 -0600 | Rating Details | |
| 2023-12-05 07:15:10 -0600 | Rating Details | |
| 2023-12-01 19:23:14 -0600 | Rating Details | |
| 2023-12-01 09:57:56 -0600 | Rating Details | |
| 2023-12-01 08:48:13 -0600 | Rating Details | |
| 2023-11-30 23:47:20 -0600 | Rating Details | |
| 2023-11-30 21:49:50 -0600 | Rating Details | |
| 2023-11-30 14:14:52 -0600 | Rating Details |